ICU
SeaStar Medical Holding Corp
Next earnings Aug 11, 2026 · consensus $-0.94 EPS, $491K rev
Last earnings -5.0% on 2026-05-13
$3.12
▲ +4.70%$3.12▼ -6.02%
over 1Y
L $2.21EODHDH $12.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.7%
1W-3.7%
1M-13.1%
3M+13.9%
YTD+18.6%
1Y-6.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 5 analysts
Buy
Revenue grew 814.1% YoY; but unprofitable (net margin -984.6%).
Revenue (FY2025) $1.23M · FY2025
SeaStar Medical Holding Corp shows $1.23M in FY2025 revenue (+814.1% YoY), a -984.6% net margin, and -116.6% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $135K | $1.23M |
| Gross profit | — | — | $0.00 | $135K | $1.18M |
| Operating income | -$4.45M | -$11.6M | -$14.2M | -$17.8M | -$12.2M |
| Net income | -$4.60M | -$12.2M | -$26.2M | -$24.8M | -$12.2M |
| Diluted EPS | -$0.63 | -$1.48 | -$30.26 | -$6.63 | — |
| Net margin | — | — | — | -18392.6% | -984.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$15.4M
EV / EBITDA—
EV / Sales12.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-97.5%
FCF yield—
Quality & risk
ROIC (est.)-63.6%
Free cash flow—
Total debt$4.72M
Net cash-$2.90M
Altman Z-Score-14.92 distress
Piotroski F-Score5/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-54.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗8-K/APeriod ending 2025-08-132026-06-23open ↗8-KPeriod ending 2026-06-172026-06-17open ↗424B3Filing2026-05-13open ↗10-QPeriod ending 2026-03-312026-05-13open ↗SCHEDULE 13G/AFiling2026-05-13open ↗8-KPeriod ending 2026-05-132026-05-13open ↗EFFECTFiling2026-05-11open ↗SCHEDULE 13GFiling2026-05-11open ↗CORRESPFiling2026-05-08open ↗S-1/AFiling2026-05-07open ↗EFFECTFiling2026-05-05open ↗EFFECTFiling2026-05-05open ↗
Frequently asked
- Is SeaStar Medical Holding Corp (ICU) a buy?
- ICU currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 814.1% YoY; but unprofitable (net margin -984.6%).
- What is SeaStar Medical Holding Corp's quality score?
- ICU scores 52.803921568627445/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001831868, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 8:37:52 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.